CSBR
Champions Oncology Inc
4.90$
+1.2%
vs. previous close
Closing price · As of: Oct 2, 2026
Statements
Income Statement
All figures as a percentage of revenue in the same period.
Tick rows to compare them in a chart (up to 4)
| Line item | 1997 | 1998 | 1999 | 2000 | 2001 | 2002 | 2003 | 2004 | 2005 | 2006 | 2007 | 2008 | 2009 | 2010 | 2011 | 2012 | 2013 | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | – | – | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | |
| 48.1% | 51.9% | 53.2% | 82.1% | 29.4% | 28.0% | 25.0% | 30.1% | 30.8% | – | – | 35.0% | 51.4% | 39.1% | 51.0% | 68.5% | 64.0% | 54.2% | 86.1% | 77.7% | 63.0% | 52.1% | 52.7% | 52.9% | 52.3% | 48.1% | 54.8% | 58.6% | 49.9% | 52.0% | |
| 51.9% | 48.1% | 46.8% | 17.9% | 70.6% | 72.0% | 75.0% | 69.9% | 69.2% | – | – | 65.0% | 48.6% | 60.9% | 49.0% | 31.5% | 36.0% | 45.8% | 13.9% | 22.3% | 37.0% | 47.9% | 47.3% | 47.1% | 47.7% | 51.9% | 45.2% | 41.4% | 50.1% | 48.0% | |
| – | – | – | – | – | – | – | – | – | – | – | 14.3% | 46.4% | 55.1% | 42.9% | 41.1% | 23.1% | 19.6% | 54.7% | 37.5% | 27.9% | 21.7% | 17.7% | 18.2% | 17.5% | 19.1% | 21.4% | 19.0% | 12.0% | 15.3% | |
| 45.8% | 42.9% | 43.2% | 14.8% | 77.5% | 75.2% | 79.8% | 13.9% | 80.2% | – | – | 85.3% | 55.4% | 56.6% | 67.0% | 76.2% | 55.6% | 53.0% | 60.3% | 46.3% | 32.2% | 20.1% | 17.3% | 20.6% | 15.9% | 18.6% | 19.0% | 22.1% | 16.4% | 18.8% | |
| 48.6% | 45.1% | 45.9% | 17.2% | 92.2% | 79.0% | 82.3% | 75.3% | 75.1% | – | – | 96.4% | 111.4% | 120.7% | 125.1% | 158.3% | 110.7% | 100.0% | 163.2% | 114.6% | 81.2% | 54.6% | 46.3% | 53.1% | 46.9% | 50.6% | 53.4% | 55.2% | 41.6% | 49.9% | |
| 3.2% | 3.0% | 0.9% | 0.7% | -21.5% | -6.9% | -7.3% | -5.4% | -5.9% | – | – | -31.4% | -62.8% | -59.8% | -76.1% | -126.8% | -74.7% | -54.2% | -149.4% | -92.3% | -44.2% | -6.7% | 1.0% | -6.0% | 0.9% | 1.2% | -8.3% | -13.8% | 8.5% | -1.9% | |
| 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | – | – | 0.0% | 2.4% | 0.1% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.1% | 2.2% | 0.2% | 0.0% | – | 0.1% | 0.0% | – | |
| 3.2% | 15.5% | 0.9% | 1.5% | -21.5% | -6.9% | -7.3% | -5.4% | -5.9% | – | – | -29.4% | -60.4% | -59.7% | -55.1% | -121.2% | -75.9% | -64.0% | -146.8% | -92.6% | -44.5% | -7.1% | 0.9% | -6.1% | 1.1% | 1.2% | -9.8% | -14.6% | 8.1% | -1.6% | |
| -10.2% | 0.4% | – | -1.7% | 9.6% | – | – | – | – | – | – | – | 5.3% | – | 0.2% | 0.0% | 0.1% | 0.1% | 1.4% | 0.8% | 0.1% | 0.2% | 0.4% | 0.4% | 0.2% | 0.1% | 0.1% | -0.1% | -0.1% | 0.4% | |
| 13.4% | 15.5% | 0.9% | 2.4% | -31.1% | -6.9% | -7.3% | -5.4% | -13.7% | – | – | -29.4% | -60.4% | -59.7% | -55.2% | -121.1% | -76.1% | -64.1% | -148.3% | -93.4% | -44.7% | -7.3% | 0.5% | -6.5% | 0.9% | 1.1% | -9.9% | -14.5% | 8.3% | -2.0% | |
| 5.6% | 18.5% | 3.6% | 3.1% | -19.0% | -4.6% | -4.9% | -3.0% | -5.9% | – | – | -31.4% | -55.0% | -59.2% | -75.5% | -125.3% | -72.3% | -52.4% | -146.9% | -90.9% | -43.1% | -4.9% | 3.2% | -2.4% | 3.8% | 4.5% | -5.6% | -10.8% | 11.0% | 0.8% |
Data as of: October 2, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.